Asian Spectator

Times Advertising

NapaJen Pharma Closes $12.4 Million Series C Financing

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
TOKYO and BURLINGAME Calif., Jan. 9, 2019 /Kyodo JBN- AsiaNet/ -- NapaJen Pharma, Inc., a biotherapeutics company leveraging its proprietary immune cell-targeted oligonucleotide delivery technology to develop novel immunotherapeutic agents, has announced the closing of a $12.4 million Series C financing deal. Th...

Read more https://view-release/?pr-id=76992

Magazine

Jangan asal FOMO padel: Tidak semua olahraga cocok buat tubuh kita

● Pilihan olahraga perlu menyesuaikan tipe tubuh.● Cara ini akan memaksimalkan aktivitas fisik dan kurangi risiko cedera.● Tipe tubuh memengaruhi kemampuan fisik membentuk otot dan m...

Bahaya bertanya ke AI: Separuh jawaban kesehatan menyesatkan, meski terdengar meyakinkan

Ilustrasi AI.Who is Danny/Shutterstock.comBayangkan kamu baru saja didiagnosis kanker stadium awal. Sebelum janji temu berikutnya dengan dokter, kamu bertanya ke chatbot berbasis kecerdasan buatan (AI...

Why Contractors Suction Hose Solutions Are Essential For Heavy-Duty Fluid Handling

In industries where materials move as relentlessly as time itself, equipment must match that intensity. Whether on construction sites, agricultural operations, or large-scale industrial setups, flui...